Skip to main content
AIBD Regionals Main banner

Full Schedule

  1. Home
  2. Full Schedule

Full Schedule

  • Friday, July 21, 2023
  • 12:00 PM - 12:15 PM .
    Session I
  • 12:15 PM - 1:00 PM .
    Session I - 2023 Updates in IBD Management
    Speaker: Millie D. Long, MD, MPH, FACG – University of North Carolina at Chapel Hill
    Speaker: Florian Rieder, MD – Cleveland Clinic
  • 1:15 PM - 2:15 PM .
    Non-CME Innovation Theater
  • 2:45 PM - 3:30 PM .
    Session II - Optimizing Existing Therapies in the Management of IBD
    Speaker: Jessica R. Allegretti, MD,MPH, FACG, AGAF – Brigham and Women's Hospital, Harvard Medical School
  • 3:45 PM - 4:45 PM .
    Non-CME Innovation Theater
  • 5:00 PM - 5:45 PM .
    Session III - Strategies to Address Barriers and Optimize Outcomes in Luminal Crohn’s Disease
    Speaker: Florian Rieder, MD – Cleveland Clinic
  • Saturday, July 22, 2023
  • 8:00 AM - 8:15 AM .
    Session IV
  • 8:15 AM - 9:00 AM .
    Session IV - Advances in Fistulizing Crohn’s Disease: Emerging Therapies and Patient-Centric Management Strategies
    Speaker: Scott A. Strong, MD, FACS, FASCRS – Northwestern University Feinberg School of Medicine
  • 9:15 AM - 10:30 AM .
    Session V - Utilizing our Therapeutic Armamentarium: Right Patient/Right Drug
    Speaker: David T. Rubin, MD, FACG (he/him/his) – University of Chicago Medicine
    Speaker: Florian Rieder, MD – Cleveland Clinic
    Speaker: Gil Y. Melmed, MD, MS, FACG, AGAF – Cedars-Sinai Medical Center
  • 10:30 AM - 11:00 AM .
    Exhibit Hall Break
  • 11:00 AM - 12:00 PM .
    Non-CME Innovation Theater
  • 12:15 PM - 1:00 PM .
    Session VI - Special Situations in IBD
    Speaker: Christina Y. Ha, MD, FACG, AGAF – Mayo Clinic Scottsdale
    Speaker: Stefan D. Holubar, MD, MS, FACS, FASCRS (he/him/his) – Cleveland Clinic
  • 1:00 PM - 1:45 PM .
    Session VII - Harnessing the Utility of Selective Sphingosine 1-Phosphate Receptor Modulators to Optimize Patient Care in IBD
    Speaker: Raymond K. Cross, Jr., MD, MS, AGAF, FACG (he/him/his) – University of Maryland School of Medicine
  • 2:00 PM - 3:00 PM .
    Non-CME Innovation Theater
  • 3:15 PM - 4:00 PM .
    Session VIII - Increasing Access to Improve Outcomes: Exploring the Role of Biosimilars in the Management of Inflammatory Bowel Disease
    Speaker: Christina Y. Ha, MD, FACG, AGAF – Mayo Clinic Scottsdale
  • 4:00 PM - 4:45 PM .
    Session IX - Putting your knowledge to the test: Challenging IBD cases